Q2 and H1 Highlights and Financial Summary
(Unaudited, all revenue growth at constant currency)
· Q2 total non-IFRS revenue and software revenue up 13% and 12%, respectively, at high end of Dassault Systèmes’ financial objectives range
· On an organic basis, non-IFRS revenue up 10% & non-IFRS software revenue up 9% in Q2
· 3DEXPERIENCE non-IFRS software revenue up 40% in H1
· Solid Core and Diversification Industries performance for H1
· Cash flow from operations up 38% to €894 million for H1
· Dassault Systèmes and Medidata signed definitive acquisition agreement on June 12, 2019
· Confirming and Updating 2019 Financial Objectives: Targeting non-IFRS EPS of €3.45-3.50, well aligned with our five-years plan to double non-IFRS earnings per share in 2019
| In millions of Euros, except per share data |
|
IFRS |
|
IFRS |
||||||
| |
Q2 2019 |
Q2 2018 |
Change |
Change in cc* |
|
YTD 2019 |
YTD 2018 |
Change |
Change in cc* |
|
| Total Revenue |
|
961.4 |
827.8 |
16% |
13% |
|
1,920.3 |
1,646.4 |
17% |
13% |
| Software Revenue |
|
847.4 |
740.1 |
15% |
12% |
|
1,702.7 |
1,475.2 |
15% |
12% |
| Operating Margin |
|
18.9% |
20.4% |
-1.4pt |
|
|
20.7% |
21.1% |
-0.4pt |
|
| EPS |
|
0.51 |
0.50 |
2% |
|
|
1.13 |
1.02 |
11% |
|
| In millions of Euros, except per share data |
|
Non-IFRS |
|
Non-IFRS |
||||||
| |
Q2 2019 |
Q2 2018 |
Change |
Change in cc* |
|
YTD 2019 |
YTD 2018 |
Change |
Change in cc* |
|
| Total Revenue |
|
965.4 |
830.7 |
16% |
13% |
|
1,929.4 |
1,651.3 |
17% |
13% |
| Software Revenue |
|
851.0 |
743.0 |
15% |
12% |
|
1,710.5 |
1,480.0 |
16% |
12% |
| Operating Margin |
|
30.7% |
29.4% |
+1.3pt |
|
|
31.8% |
30.4% |
+1.4pt |
|
| EPS |
|
0.82 |
0.69 |
19% |
15% |
|
1.69 |
1.41 |
20% |
14% |
Bernard Charlès, Dassault Systèmes’ Vice Chairman and Chief Executive Officer commented, “We believe the 3DEXPERIENCE platform is a critical enabler for innovation and transformation across all major industries where the drive to provide new types of customer experiences and new business models is emerging and accelerating. We see these possibilities across the three spheres addressed by our purpose: Product, Nature and Life and the proof points with our strategic wins across a number of diverse industries over the last two years.
“Our plan to acquire Medidata, announced in June, fits perfectly into our strategy in that regard. As the Life Sciences industry shifts to science-based experience, we believe scientific innovation and industrial performance call for a unified new approach and this is what we have been working towards with our investments in Life Sciences over the past years. The acquisition of Medidata, with its clinical and commercial solutions, reinforces our position as a science-based company by providing the Life Sciences industry with an integrated business experience platform for an end-to-end approach to research and discovery, development, clinical testing, manufacturing and commercialization of new therapies and health technologies.
“Thanks to our platform strategy, more companies view us as a strategic partner to help them transform. We were very honored and pleased that Groupe PSA has named Dassault Systèmes a key supplier, and its preferred digital partner for its digital transformation. With Dassault Systèmes as Groupe PSA’s preferred digital partner, the two companies are engaging in a long-term strategy with the intent to deploy the 3DEXPERIENCE platform as a key innovation enabler across the group’s activities.”
For full results visit https://investor.3ds.com/news-releases/news-release-details/dassault-systemes-reports-first-half-revenue-and-eps-growth
